← Back to Search

Cryoneurolysis

Cryoneurolysis for Knee Pain

N/A
Recruiting
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months postoperative
Awards & highlights

Study Summary

This trial is testing a handheld device to freeze nerves and relieve pain before knee replacement surgery in order to reduce post-surgery pain and opioid use.

Eligible Conditions
  • Osteoarthritis
  • Chronic Knee Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months postoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months postoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient recruitment rate
Secondary outcome measures
EQ-5D-5L
Numeric Rating Scale of Pain
Opioid consumption
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: IoveraExperimental Treatment1 Intervention
Cryoneurolysis + standard of care: Usual intervention plus pre-operation Iovera treatment. Patients will receive local anaesthesia unilaterally to the affected knee prior to the treatment and then the anesthesiologist will administer the freezing cold therapy (Iovera device) to the affected knee.
Group II: PlaceboPlacebo Group1 Intervention
Placebo: Usual intervention plus pre-operation placebo. The placebo group will receive short-acting local anaesthesia injection unilaterally to the affected knee.

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
545 Previous Clinical Trials
450,452 Total Patients Enrolled

Media Library

Iovera - Cryoneurolysis (Cryoneurolysis) Clinical Trial Eligibility Overview. Trial Name: NCT05286996 — N/A
Osteoarthritis Research Study Groups: Iovera, Placebo
Osteoarthritis Clinical Trial 2023: Iovera - Cryoneurolysis Highlights & Side Effects. Trial Name: NCT05286996 — N/A
Iovera - Cryoneurolysis (Cryoneurolysis) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05286996 — N/A
~8 spots leftby May 2025